Resources

This brief highlights the importance of increased investment in research and development for health in Kenya.

The Community Mobilization and Action Planning workshop was created as an addendum to PATH’s three-day policy advocacy strategy development curriculum, which aims to increase the understanding and skills among individuals and organizations to plan, facilitate, and implement policy advocacy strategies to bring about change. Using PATH’s 10-part framework for assessing policy advocacy options and making strategic decisions about goals and activities, Advocacy for Better Health developed this Community Mobilization and Action Planning workshop focused on community-level advocacy and health-related change.

PATH's Digital Health Solutions (DHS) program works across health domains such as immunization, supply chain, maternal and child health, and insurance to identify and address information management needs and improve data-driven decision-making at the country and global levels.

This brief provides a clinical overview of the injectable contraceptive subcutaneous DMPA (DMPA-SC or Sayana® Press), which contains 30% less depot medroxyprogesterone acetate than the intramuscular presentation of Depo-Provera®. DMPA-SC is administered subcutaneously through the prefilled Uniject injection system, an autodisable injection device. For more information, visit www.path.org/dmpa-sc, sign up for our newsletter, or email FPoptions@path.org.

This fact sheet describes PATH’s Center for Vaccine Innovation and Access (CVIA), which was launched in 2016 to strengthen, accelerate, and coordinate PATH’s broad range of work across the vaccine spectrum.